Position in ENGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,241,596
+$193,251 QoQ
Shares Held
717,686
+366.2% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 60 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENGN Over Time
Shares Held
Position Value (USD)
Derivatives in ENGN
reported options exposure · as of Jun 30, 2026CallValue
$53,284
CallShares
30,800
PutValue
$56,744
PutShares
32,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. ENGN ranks #217 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in ENGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,241,596 | 717,686 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $56,744 | 32,800 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $53,284 | 30,800 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,048,345 | 153,942 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $229,208 | 25,383 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $398,667 | 58,370 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $83,876 | 23,043 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $5,783,343 | 613,292 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,630,816 | 804,178 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $185,126 | 20,057 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||